Melodiol Global Health Achieves 80% Remission Rate From Phase Two Hallucinogenic Trial
Melodiol Global Health Achieves 80% Remission Rate From Phase Two Hallucinogenic Trial
Melodiol Global Health 第二階段致幻試驗實現了 80% 的緩解率
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊